Yomeishu Seizo Co., Ltd. (2540) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

euglena Co., Ltd.

O'will Corp.

Ohki Health Care Holdings, Inc.

CB GROUP MANAGEMENT Co., Ltd.

Kissei Pharmaceutical Co., Ltd.

Yomeishu Seizo Co., Ltd.

Astena Holdings Co., Ltd.

Morishita Jintan Co., Ltd.

NANO MRNA Co., Ltd.

CellSeed, Inc.

Pharma Foods International Co., Ltd.

Why is Yomeishu Seizo Co., Ltd. ?

Poor Management Efficiency with a low ROE of 2.04%

The company has been able to generate a Return on Equity (avg) of 2.04% signifying low profitability per unit of shareholders funds

Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 45.05

Poor long term growth as Net Sales has grown by an annual rate of -0.90% over the last 5 years

Flat results in Jun 25

DEBT-EQUITY RATIO (HY) Highest at -11.08 %
RAW MATERIAL COST(Y) Grown by 7.27% (YoY)
CASH AND EQV(HY) Lowest at JPY 10,764.97 MM

With ROE of 1.53%, it has a expensive valuation with a 1.09 Price to Book Value

The stock is trading at a premium compared to its peers' average historical valuations
Over the past year, while the stock has generated a return of 67.25%, its profits have fallen by -26.1%

Market Beating Performance

The stock has generated a return of 67.25% in the last 1 year, much higher than market (Japan Nikkei 225) returns of 38.59%

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Yomeishu Seizo Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Yomeishu Seizo Co., Ltd. for you?

Medium Risk, High Return

Absolute

Risk Adjusted

Volatility

Yomeishu Seizo Co., Ltd.

-100.0%

2.42

38.78%

Japan Nikkei 225

38.59%

1.45

26.59%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-0.90%

EBIT Growth (5y)

-26.52%

EBIT to Interest (avg)

45.05

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.12

Sales to Capital Employed (avg)

0.22

Tax Ratio

30.22%

Dividend Payout Ratio

91.69%

Pledged Shares

Institutional Holding

ROCE (avg)

1.90%

ROE (avg)

2.04%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.09

EV to EBIT

348.37

EV to EBITDA

53.84

EV to Capital Employed

1.11

EV to Sales

4.46

PEG Ratio

Dividend Yield

ROCE (Latest)

0.32%

ROE (Latest)

1.53%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bullish

Bollinger Bands

Mildly Bearish

Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

10What is working for the Company

INTEREST COVERAGE RATIO(Q)

The company hardly has any interest cost

OPERATING PROFIT(Q)

Highest at JPY 294.32 MM

OPERATING PROFIT MARGIN(Q)

Highest at 12.59 %

DEBTORS TURNOVER RATIO(HY)

Highest at 4.42%

NET PROFIT(Q)

Highest at JPY 310.83 MM

EPS(Q)

Highest at JPY 21.69

-4What is not working for the Company

DEBT-EQUITY RATIO (HY)

Highest at -11.08 %

RAW MATERIAL COST(Y)

Grown by 7.27% (YoY

CASH AND EQV(HY)

Lowest at JPY 10,764.97 MM

Here's what is working for Yomeishu Seizo Co., Ltd.

Operating Profit

Highest at JPY 294.32 MM and Grown

In each period in the last five periods

MOJO Watch

Near term Operating Profit trend is quite positive

Operating Profit (JPY MM)

Operating Profit Margin

Highest at 12.59 % and Grown

In each period in the last five periods

MOJO Watch

Company's profit margin has improved

Operating Profit to Sales

Net Profit

Highest at JPY 310.83 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (JPY MM)

EPS

Highest at JPY 21.69

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (JPY)

Debtors Turnover Ratio

Highest at 4.42%

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Here's what is not working for Yomeishu Seizo Co., Ltd.

Debt-Equity Ratio

Highest at -11.08 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Cash and Eqv

Lowest at JPY 10,764.97 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents

Raw Material Cost

Grown by 7.27% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales